Status:
COMPLETED
Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Conditions:
Parkinson's Disease
Eligibility:
All Genders
30+ years
Brief Summary
The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed...
Eligibility Criteria
Inclusion
- Male or Female at least 30 years of age
- Willing to be assessed using the motor examination section of the UPDRS and the SPES/SCOPA motor evaluation
- Patients must be willing and able to give written informed consent prior to performing an study procedures
- Be in the "ON" State (only for patients who fluctuate between "ON" and "OFF" states)
Exclusion
- Absence of bradykinesia at the time of assessment
- Hoehn and Yahr stage not available from patient's chart or not assessed between 3 and 180 days prior to clinic visit
- Has received and experimental drug within the last thirty (30) days
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00932581
Start Date
June 1 2009
End Date
December 1 2009
Last Update
April 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.